uridine monophosphate has been researched along with Anemia, Cooley's in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abd-Elsalam, S; Abdellatif, RS; Abo-Amer, YE; Elbedewy, TA; Elsebaey, MA; Fouad, A; Mostafa, SM; Youssef, M | 1 |
| Abbassi, MM; Ebeid, FS; El-Baraky, IA; El-Sayed, MH; Hassany, M; Sabry, NA | 1 |
| Diaz, JJ; Erales, J; Francina, A; Fucharoen, S; Hacot, S; Joly, P; Lithanatudom, P; Mertani, HC; Smith, DR; Sornjai, W; Svasti, S | 1 |
3 other study(ies) available for uridine monophosphate and Anemia, Cooley's
| Article | Year |
|---|---|
Sofosbuvir/Ledipasvir for Treatment of Chronic Hepatitis C Infection in Adult Patients with β- Thalassemia Major: A Real-Life Study.
Topics: Adult; Antiviral Agents; Benzimidazoles; beta-Thalassemia; Drug Therapy, Combination; Fluorenes; Genotype; Hepatitis C, Chronic; Humans; Retrospective Studies; Sofosbuvir; Thalassemia; Treatment Outcome; Uridine Monophosphate | 2022 |
Beta-thalassemia major alters sofosbuvir/ledipasvir exposure in Hepatitis C virus infected adolescent patients.
Topics: Adolescent; Adult; Antiviral Agents; Benzimidazoles; beta-Thalassemia; Drug Therapy, Combination; Fluorenes; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Pharmaceutical Preparations; Prospective Studies; Sofosbuvir; Treatment Outcome; Uridine Monophosphate | 2021 |
Hypermethylation of 28S ribosomal RNA in β-thalassemia trait carriers.
Topics: beta-Thalassemia; Case-Control Studies; Chromosomal Proteins, Non-Histone; Gene Expression; Hematopoietic Stem Cells; Hemoglobin E; Heterozygote; Humans; Leukocytes, Mononuclear; Methylation; Primary Cell Culture; Protein Biosynthesis; Ribosomes; RNA Processing, Post-Transcriptional; RNA, Ribosomal, 28S; RNA, Small Nucleolar; Uridine Monophosphate | 2017 |